La vendita allo scoperto per ImmunityBio dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di ImmunityBio. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

ImmunityBio (NASDAQ:IBRX) Azioni, Report sulle vendite allo scoperto

ImmunityBio

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: United states and Europe. Key revenue is generated from Europe.

ImmunityBio Inc

Earnings

Earnings Beats

News

PINC

Premier Q1 2025 Adj. EPS $0.34 Beats $0.25 Estimate, Sales $248.142M Beat $232.843M Estimate

Restaurant Brands Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QSR#NYSE">QSR</a>) reported quarterly earnings of $0.93 per share which missed the analyst consensus estimate of $0.95 by 2.11 percent. The company reported quarterly sales of $2.291 billion which missed the analyst consensus estimate of $2.307 billion by 0.69 percent. This is a 24.71 percent increase over sales of $1.837 billion the same period last year.

Earnings Misses

Restaurant Brands Intl Q3 2024 Adj. EPS $0.93 Misses $0.95 Estimate, Sales $2.291B Miss $2.307B Estimate

Edward Jones analyst David Heger downgrades BCE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BCE#NYSE">BCE</a>) from Buy to Hold.

Downgrades

Analyst Ratings

Edward Jones Downgrades BCE to Hold

B of A Securities analyst Dariusz Lozny upgrades MDU Resources Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MDU#NYSE">MDU</a>) from Neutral to Buy and lowers the price target from $31 to $17.

Upgrades

Price Target

B of A Securities Upgrades MDU Resources Gr to Buy, Lowers Price Target to $17

TD Cowen analyst Yaron Werber initiates coverage on Upstream Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPB#NASDAQ">UPB</a>) with a Buy rating.

Initiation

TD Cowen Initiates Coverage On Upstream Bio with Buy Rating

Amazon.Com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) Amazon Prime Video is unveiling an X-Ray Recaps feature to help users stay updated on their favorite shows, even after <a target="_blank" href="https://www.aboutamazon.com/news/entertainment/amazon-prime-video-x-ray-recaps" rel="noreferrer noopener">long breaks between episodes</a>.
Instead of rewinding or searching for plot summaries, viewers can now access spoiler-free, AI-generated recaps to refresh their memory quickly.
X-Ray Recaps uses generative AI to create concise summaries tailored to a user&#8217;s specific point in an episode or season.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41722824/apples-services-and-silicon-strategy-to-fuel-margins-justify-high-valuation-analyst" rel="noreferrer noopener">Apple&#8217;s Services And Silicon Strategy To Fuel Margins, Justify High Valuation: Analyst</a>
Whether viewers need a refresher on critical events halfway through a season or have missed crucial plot points, X-Ray Recaps provides clear, relevant context in short text segments.
This feature extends Prime Video&#8217;s existing X-Ray tool, which already offers cast, soundtrack, and trivia information to enhance the viewing experience.
Amazon&#8217;s new feature leverages Amazon Bedrock, an AWS service for creating and scaling AI applications.
The feature combines Bedrock&#8217;s AI and customized models trained on Amazon SageMaker to analyze video segments and subtitles to generate comprehensive yet spoiler-free summaries.
Guardrails ensure that the recaps avoid spoilers and keep the content concise, making it ideal for audiences eager to return to their shows without missing key developments.
Prime Video users can access X-Ray Recaps directly from the detail page or during playback within the X-Ray experience. Once activated, options include summaries for the current episode, the season, or the previous season.
The feature is currently in beta and is available to U.S. customers on Fire TV, with broader device support expected by the end of the year.
At launch, X-Ray Recaps will cover the Amazon MGM Studios Original series.
The move marks Amazon&#8217;s efforts to stay relevant versus streaming giants like Netflix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>). Amazon Prime Video started offering lower ad prices than Netflix and other streaming rivals as it competes <a target="_blank" href="https://www.benzinga.com/news/24/07/40042764/amazon-challenges-netflix-with-cheaper-ad-slots-boosts-prime-video-ads-report" rel="noreferrer noopener">for advertiser interest</a>.
Bernstein analyst Mark Shmulik noted Amazon as a substantial investment, even with upcoming <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41737293/amazon-stock-buy-now-pay-off-later-says-analyst" rel="noreferrer noopener">infrastructure spending increases</a>. Shmulik sees Amazon&#8217;s core operations, AWS revenue, and Prime Video investments as key drivers, especially before the holiday season.
He emphasized that Amazon&#8217;s spending tends to yield solid returns, setting up for strong free cash flow in 2025.
<a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41692259/amazon-analysts-see-growth-ahead-with-aws-in-early-innings-of-a-big-ai-cycle-advert" rel="noreferrer noopener">Analysts view Amazon Prime Video</a> as a strategic growth driver within Amazon&#8217;s expanding advertising segment. The recent introduction of Prime Video&#8217;s ad-supported tier will likely boost Amazon&#8217;s advertising revenue, with analysts like Truist&#8217;s Youssef Squali projecting significant contributions by fiscal 2025. BMO Capital&#8217;s Brian Pitz also noted that sports content and new AI-driven bidding tools could further enhance ad revenue potential.
Price Action: AMZN stock traded higher by 0.13% to $196.03 premarket at the last check on Tuesday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41720954/disney-creates-new-tech-hub-for-ai-and-ar" target="_blank" rel="noreferrer noopener">Disney Creates New Tech Hub For AI and AR</a></li>
</ul>
Photo via Shutterstock

Tech

AMZN

NFLX

Amazon Takes on Netflix With New AI Recaps

TD Cowen analyst Joshua Jennings initiates coverage on CeriBell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBLL#NASDAQ">CBLL</a>) with a Buy rating and announces Price Target of $31.

CBLL

TD Cowen Initiates Coverage On CeriBell with Buy Rating, Announces Price Target of $31

B of A Securities analyst Ross Fowler upgrades Idacorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IDA#NYSE">IDA</a>) from Neutral to Buy and raises the price target from $113 to $117.

B of A Securities Upgrades Idacorp to Buy, Raises Price Target to $117

Contracts

RDWR

Radware Expands Customer Relationship With A Prominent US Based Communications Platform As A Service Provider In Multimillion-Dollar Deal

Emeren Enters Co-Development Agreement With Arpinge To Jointly Develop A 300 MW Battery Energy Storage System Portfolio In Southern Italy

Taiwan Semiconductor Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) remains vulnerable to Taiwan&#8217;s surging electricity prices, a shift that could impact the semiconductor industry.
Once a competitive edge, Taiwan&#8217;s low-cost energy has become more challenging to maintain, leading to increased costs for major industrial consumers, the Financial Times <a target="_blank" href="https://www.ft.com/content/cfd77e84-5d5b-47ae-96bd-9973b1c18662" rel="noreferrer noopener">reports</a>.
Taiwan Semiconductor now anticipates that electricity expenses in Taiwan will surpass those in its other significant locations, including the U.S., Japan, and Germany.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/24/10/41633790/apple-refreshes-macbook-pro-lineup-with-m4-pro-and-m4-max-3nm-chips" rel="noreferrer noopener">Apple Refreshes MacBook Pro Lineup With M4 Pro and M4 Max 3Nm Chips</a>
<a target="_blank" href="https://www.benzinga.com/markets/equities/24/11/41706702/nvidia-supplier-tsmc-to-double-advanced-chip-packaging-capacity-as-ai-demand-from-microsoft-amaz" rel="noreferrer noopener">Recent reports indicated</a> the chipmaker will double its advanced packaging capacity by 2025, largely to meet the rising demand for AI chips from major tech firms like Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>). The company&#8217;s CoWoS packaging technology is in high demand, with Nvidia expected to use more than half of the expanded capacity.
CFO Wendell Huang recently disclosed to investors that power costs in Taiwan have effectively doubled over the past few years and will likely be Taiwan Semiconductor&#8217;s highest globally by 2024.
Taiwan&#8217;s government has raised electricity prices four times since 2022, with increases primarily affecting industrial users like Taiwan Semiconductor.
In line with its broader energy transition, Taiwan aims to boost renewable energy to supply up to 30% of its power by 2030. However, a recent emphasis on scaling back coal and nuclear power has made it increasingly challenging to meet industrial demands.
According to FT, Taiwan relies on coal and liquefied natural gas for over 80% of its energy supply, with renewable sources accounting for only 9.5%.
The rising electricity rates alone may not significantly hinder Taiwan Semiconductor&#8217;s operations, as power costs constitute a minor portion of its overall expenses. However, consistent supply disruptions could threaten Taiwan Semiconductor&#8217;s ability to expand its production capacity in Taiwan, FT writes.
Taiwan Semiconductor stock has gained 89% year-to-date. Investors can gain exposure to the stock through the iShares Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOXX#NASDAQ">SOXX</a>) and the First Trust NASDAQ Technology Dividend Index Fund (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TDIV#NASDAQ">TDIV</a>).
Price Actions:&nbsp;TSM stock traded higher by 1.17% to $193.80 premarket at the last check on Tuesday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/government/24/11/41726213/applied-materials-and-lam-research-shift-supply-chains-away-from-china-to-meet-new-us-guidelines" target="_blank" rel="noreferrer noopener">Applied Materials and Lam Research Shift Supply Chains Away from China to Meet New US Guidelines</a></li>
</ul>
Photo by wakamatsu.h via Shutterstock

Government

Regulations

Media

MSFT

NVDA

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

TDIV

Taiwan Semiconductor Faces Rising Energy Costs, Potential Outages Threaten Production

As the United States approaches the election, Trump Media &amp; Technology Group Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) has seen a notable 5.15% increase in pre-market trading on Tuesday, as per <a href="https://pro.benzinga.com">Benzinga Pro</a>. This surge comes as traders perceive the company&#8217;s stock as a potential indicator of Donald Trump&#8217;s reelection chances.
What Happened: The recent uptick in Trump Media &amp; Technology Group&#8217;s stock is linked to the upcoming U.S. elections. On Monday, DJT closed 12.37% higher at $34.34.
Traders are treating Trump&#8217;s stock as a gauge for his reelection prospects. If Trump wins, his platform, Truth Social, is expected to play a significant role in his communication strategy, akin to his use of X during his presidency, according to <a href="https://www.cnbctv18.com/world/share-of-donald-trumps-social-media-firm-surge-on-eve-of-the-us-election-day-19503834.htm">CNBC</a>. However, if Vice President Kamala Harris wins, the future of Truth Social could face challenges.
See Also: <a href="https://www.benzinga.com/news/24/11/41710411/market-analyst-who-predicted-trumps-2016-win-and-bidens-2020-victory-now-sees-former-president-retak?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Market Analyst Who Predicted Trump&#8217;s 2016 Win And Biden&#8217;s 2020 Victory, Now Sees Former President Retaking The White House With &#8216;Large Majority Of Swing States&#8217;</a>
This development is occurring as the nation gears up for a pivotal election, with market participants closely watching political dynamics. The performance of Trump Media &amp; Technology Group&#8217;s stock reflects broader sentiments regarding the election&#8217;s potential outcomes and their implications for Trump&#8217;s media ventures.
Why It Matters: The election race between Trump and Harris has tightened, with recent polls showing <a href="https://www.benzinga.com/general/politics/24/11/41733277/harris-vs-trump-vice-president-has-two-point-lead-in-final-election-poll-swing-states-remain-clo">Harris maintaining a slight lead</a> over Trump. However, her lead has been shrinking, indicating a closely contested election. This uncertainty adds to the volatility surrounding Trump Media &amp; Technology Group&#8217;s stock.
Additionally, options activity for <a href="https://www.benzinga.com/insights/options/24/11/41717863/this-is-what-whales-are-betting-on-trump-media-technology">Trump Media &amp; Technology</a> has seen significant movement, with deep-pocketed investors showing a divided sentiment. While 36% of these investors are bullish, 48% are bearish, indicating mixed expectations about the company&#8217;s future. 
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/asia/24/11/41722178/if-trump-and-republicans-sweep-dollar-may-climb-7-but-harris-win-could-bring-5-drop-says-jpmorgan?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">If Trump And Republicans Sweep, Dollar May Climb 7% — But Harris Win Could Bring 5% Drop, Says JPMorgan</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Image via Shutterstock

Equities

Pre-Market Outlook

Markets

General

Trump Media (DJT) Stock Rises Over 6% In Pre-Market Ahead Of Presidential Election Eve

Vishay Precision Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VPG#NYSE">VPG</a>) sees Q4 sales of $70.000 million-78.000 million vs $79.10 million estimate.

Guidance

Vishay Precision Group Sees Q4 Sales $70.000M-78.000M vs $79.10M Est

TD Cowen analyst Bill Katz downgrades Affiliated Managers Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMG#NYSE">AMG</a>) from Buy to Hold and lowers the price target from $226 to $177.

TD Cowen Downgrades Affiliated Managers Group to Hold, Lowers Price Target to $177

Vishay Precision Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VPG#NYSE">VPG</a>) reported quarterly earnings of $0.19 per share which missed the analyst consensus estimate of $0.26 by 26.92 percent. This is a 59.57 percent decrease over earnings of $0.47 per share from the same period last year. The company reported quarterly sales of $75.73 million which missed the analyst consensus estimate of $76.71 million by 1.28 percent. This is a 11.80 percent decrease over sales of $85.85 million the same period last year.

Vishay Precision Group Q3 Adj $0.19 Misses $0.26 Estimate, Sales $75.73M Miss $76.71M Estimate

CRVL

CorVel Q2 EPS $1.35 Up From $1.15 YoY, Sales $224M Up From $196M YoY

Deutsche Bank analyst Bryan Keane downgrades Marqeta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MQ#NASDAQ">MQ</a>) from Buy to Hold and lowers the price target from $9 to $4.

Deutsche Bank Downgrades Marqeta to Hold, Lowers Price Target to $4

BTIG analyst Sean Lavin downgrades Tactile Systems Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCMD#NASDAQ">TCMD</a>) from Buy to Neutral.

TCMD

BTIG Downgrades Tactile Systems Tech to Neutral

INGR

Ingredion Now Expects FY24 Net Sales To Be Down Mid-Single-Digits (Prior View: Down Low Single-Digits), Excluding Effects Of Sale Of South Korea Business

Ingredion Raises FY24 Adjusted EPS Outlook From $9.70 - $10.20 To $10.35 - $10.65, Est $9.97

ImmunityBio: Anktiva Launch, Good Data, Low Cash, High Debt

Q3 pharma and biotech layoffs in charts: More than 1000 each in July and August

ImmunityBio: Moving The Needle

EF Hutton initiated coverage of ImmunityBio (IBRX) with a Buy rating and $30 price target ImmunityBio is a late-stage clinical biotechnology compan...

ImmunityBio initiated with a Buy at EF Hutton

Immunotherapy innovator ImmunityBio (IBRX) announced that the first patients have been dosed in an initial trial studying the potential of the comp...

ImmunityBio:  1st patient dosed in CAR-NK cell therapy study relapsed NHL

ImmunityBio extends gains after trial update

ImmunityBio: Continued Volatility Suggests Further Upside Potential, But I'd Be Careful

ImmunityBio: CAR-NK Cell Therapy Data For NHL Expected In Second Half Of 2025

Unusual total active option classes on open include: Hawaiian Electric (HE), PureCycle Technologies (PCT), Rumble (RUM), ON Semiconductor (ON), Imm...

Unusually active option classes on open October 28th

Biotech ImmunityBio ($IBRX) has grabbed investors' attention. Its stock has shot up over 77% in the past few days on news of the first patients bei...

ImmunityBio's (IBRX) Plans to Bridge Gaps in Cancer Treatments, Stock Soars

ABUS

ALPMF

ALPMY

ANTX

ATHA

BAYRY

BAYZF

BBIO

BMRN

BMYMP

CDTX

CGON

CRBU

CVAC

FGEN

GLYC

HLVX

IBRX

INAB

LXRX

PGEN

QURE

RAPT

RHHBY

RILY

RLAY

RPTX

SLRN

VIRX

Legal

Press Releases

SHAREHOLDER ALERT: Morris Kandinov Investigating IBRX, AGL, XPOF and AKRO; Shareholders are Encouraged to Contact the Firm

Kuehn Law Encourages Investors of ImmunityBio, Inc. to Contact Law Firm

IMMUNITYBIO INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of ImmunityBio, Inc. - IBRX

ImmunityBio Announces Study of ANKTIVA® in Combination with the AdHER2DC Cancer Vaccine as a Potential Therapy to Control Endometrial Cancer

ImmunityBio's ANKTIVA® Now Covered By More Than a Dozen Insurance Plans Representing Over 100 Million Lives Within Months of FDA Approval

ImmunityBio Presents Positive Long-Term Overall Survival Data in Non-Small Cell Lung Cancer Patients and Announces Registrational Intent Phase 3 Trials with ANKTIVA® and Checkpoint Immunotherapy at World Conference on Lung Cancer

IMMUNITYBIO INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of ImmunityBio, Inc. - IBRX

ImmunityBio to Participate in the Jefferies London Healthcare Conference

First Patients Dosed in Phase 1 Clinical Study of ImmunityBio's CAR-NK Cell Therapy for the Treatment of Relapsed B-Cell Non-Hodgkin Lymphoma

IMMUNITYBIO ALERT: Bragar Eagel & Squire, P.C. is Investigating ImmunityBio, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Comments

ImmunityBio

Vendite allo scoperto

ImmunityBio (NASDAQ:IBRX) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO